Skip to main content
OpenTrials

Clinical trial condition

Pancreatic Diseases

Explore clinical trials studying Pancreatic Diseases. Study availability and eligibility vary by location and protocol.

4,382 public trials 841 recruiting studies
Refine in advanced search Browse all conditions

Pancreatic Diseases trial results

Completed

Safety and Efficacy of 12-wk Treatment With Two Doses of Tiotropium Respimat in Cystic Fibrosis

NCT00737100

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations
  • 205.339.006 Boehringer Ingelheim Investigational Site Tucson, Arizona, United States
  • 205.339.019 Boehringer Ingelheim Investigational Site San Diego, California, United States
  • 205.339.023 Boehringer Ingelheim Investigational Site Jacksonville, Florida, United States
  • 205.339.021 Boehringer Ingelheim Investigational Site Miami, Florida, United States
View all 107 locations
View Trial Details
Completed

Study to Evaluate the Efficacy and Safety of OraVescent Fentanyl Citrate Treatment for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Noncancer-Related Chronic Pain

NCT00343733

Conditions
Arthritis, Autonomic Nervous System Diseases, Back Pain, +25 more
Locations
  • Hot Springs Pain Clinic Hot Springs, Arkansas, United States
  • Samaritan Center for Medical Los Gatos, California, United States
  • Pacific Neuroscience Medical Group, Inc. Oxnard, California, United States
  • Centre for Rheumatology Fort Lauderdale, Florida, United States
View all 21 locations
View Trial Details
Completed

A Study of the Efficacy and Tolerability of Pancrelipase Microtablet (MT) Capsules for the Treatment of Cystic Fibrosis-dependent Exocrine Pancreatic Insufficiency

NCT00662675

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +12 more
Locations
  • Long Beach, California, United States
  • Los Angeles, California, United States
  • Orlando, Florida, United States
  • Louisville, Kentucky, United States
View Trial Details
Completed

A Study of the Comparable Efficacy and Safety of Pulmozyme (Dornase Alfa) Delivered by the eRapid Nebulizer System in Patients With Cystic Fibrosis

NCT01712334

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations
  • Phoenix, Arizona, United States
  • Little Rock, Arkansas, United States
  • Portland, Maine, United States
  • Boston, Massachusetts, United States
View all 16 locations
View Trial Details

Related conditions